Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled evaluation of epicutaneous IDEA-033 for osteoarthritis of the knee
2004-004993-95Phase 3Completed
- Sponsor
- IDEA AG
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketoprofen in osteoarthritis (OA) (4 arms), sponsored by IDEA AG. Primary endpoint: Change in WOMAC pain subscale (VAS) from baseline to Week 12. Started Jun 2005; status: completed.
02
Drugs
ketoprofen
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2004-004993-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004993-95.